Información del artículo
Los tumores gastroenteropancreáticos endocrinos (TEGEP) pertenecen al grupo de tumores neuroendocrinos. Los tumores TEGEP se diferencian, fundamentalmente, en 2 grupos: los tumores endocrinopancreáticos y los tumores carcinoides. En ambos grupos la sintomatología puede quedar producida por la producción de una hormona por el tumor. Por la localización de estos tumores, las diferentes técnicas de endoscopia digestiva juegan un papel fundamental en la localización, tipificación histológica y citológica, e incluso para su resección endoscópica. En el presente artículo se describen los distintos procedimientos endoscópicos disponibles que son útiles para la localización y el manejo de estos tumores.
Palabras clave:
Tumores endocrinos pancreáticos
Tumores carcinoides
Técnicas endoscópicas
Ultrasonografía endoscópica
Cápsula endoscópica
Gastroenteropancreatic endocrine tumors can be broadly divided into two groups: pancreatic endocrine tumors and carcinoid tumors. In both types of tumor, patients can present with a clinical syndrome related to hormone secretion by the tumor. Due to the location of these tumors, the various endoscopic techniques play a major role in their localization and histological and cytological confirmation, and even in their endoscopic resection. The present article describes the endoscopic procedures available for the localization and management of these tumors.
Key words:
Pancreatic endocrine tumors
Carcinoid tumors
Endoscopic procedures
Endoscopic ultrasonography
Capsule endoscopy
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.N. Newton, A.J. Swerdlow, I.M. Dos Santos Silva, M.P. Vessey, D.G. Grahame-Smith, P. Primatesta, et al.
The epidemiology of carcinoid tumors in England and Scotland.
Brit J Cancer, 70 (1994), pp. 939-942
[2.]
T. Berge, F. Linell.
Carcinoid tumors. Frequency in a defined population during a 12-year period.
Acta Pathol Microbiol Scand A, 84 (1976), pp. 322-330
[3.]
I.M. Modlim, K.D. Lye, M. Kidd.
A 5-decade analysis of 13715 carcinoid tumors.
Cancer, 97 (2003), pp. 934-959
[4.]
R. Arnold.
Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.
Best Pract Res Clin Gastroenterol, 19 (2005), pp. 491-505
[5.]
G. Rindi, C. Bordi, S. Rappel, S. Larosa, M. Stolte, E. Solcia.
Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology and behavior.
World J Surg, 20 (1996), pp. 168-172
[6.]
G. Rindi, C. Azzoni, S. La Rosa, C. Klersy, D. Paolotti, S. Rappel, et al.
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis.
Gastroenterology, 116 (1999), pp. 532-542
[7.]
G. Rindi, O. Luinetti, M. Cornaggia, C. Capella, E. Solcia.
Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathological study.
Gastroenterology, 104 (1993), pp. 994-1006
[8.]
T. Lehy, G. Cadiot, M. Mignon, P. Ruszniewski, S. Bonfils.
Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome.
Gut, 33 (1992), pp. 1275-1279
[9.]
P. Ruszniewski, G. Fave, G. Cadiot, P. Komminoth, D. Chung, B. Kos-Kudla, et al.
Well-differentiated Gastric Tumors/Carcinomas. ENETS guidelines.
Neuroendocrinology, 84 (2006), pp. 158-164
[10.]
I.M. Modlin, M. Kidd, I. Latich, M.N. Zikusoka, M.D. Shaphiro.
Current status of gastrointestinal carcinoids.
Gastroenterology, 128 (2005), pp. 1717-1751
[11.]
S. Gabos, J. Berkel, D. Robson, H. Whittaker.
Small bowell cancer in Western Canada.
Int J Epidemiol, 22 (1993), pp. 198-206
[12.]
B. Stamm, C.E. Hedinger, P. Saremaslani.
Duodenal and ampullary carcinoid tumors: report of 12 cases with pathological characteristics, polypeptide content and relation to MEN-I syndrome and von Recklinghausen's disease (neurofibromatosis).
Virchow Arch A, 408 (1986), pp. 475-489
[13.]
A.P. Burke, B.H. Federspiel, L.H. Sobin, K.M. Shekita, E.B. Helwig.
Carcinoids of the duodenum: a histologic and immunohistochemical study of 65 tumors.
Am J Surg Pathol, 13 (1989), pp. 828-837
[14.]
S.W. Coates Jr, D.C. De Marco.
Metastatic carcinoid tumor discovered by capsule endoscopy and not detected by esophagogastroduodenoscopy.
Dig Dis Sci, 49 (2004), pp. 639-641
[15.]
H. Yamamoto.
Total small bowell enteroscopy. From diagnosis to therapy.
2nd International Conference on capsule endoscopy,
[16.]
P.A. Akerman, D. Agrawal, D. Cantero, J. Pangtay.
Spiral enteroscopy with the new DSB overtube: a novel technique for deep peroral small-bowell intubation.
Endoscopy, 40 (2008), pp. 974-978
[17.]
Y. Okamoto, M. Fujii, S. Fateiwa, T. Sakai, F. Ochi, M. Sugano, et al.
Treatment of multiple rectal carcinoids by endoscopic mucosal rresection using a device for esophageal variceal ligation.
Endoscopy, 36 (2004), pp. 469-470
[18.]
C. Spread, H. Berkel, L. Jewell, H. Jenkins, W. Yakimets.
Colon carcinoid tumors: a population based study.
Dis Colon Rectum, 37 (1994), pp. 482-491
[19.]
D.C. Metz.
Diagnosis and treatment of pancreatic neuroendocrine tumors.
Seminars in Gastrointestinal Disease, 6 (1995), pp. 67-78
[20.]
B. Skogseid, K. Oberg, B. Erikson, C. Juhlin, D. Granberg, G. Akerström, et al.
Surgery for asymtomatic pancreatic lesion in multiple endocrine neoplasia type 1.
World J Surg, 20 (1996), pp. 827-877
[21.]
C.S. Grand.
Gastrointestinal endocrine tumors. Insulinoma.
Baillieres Clin Gastroenterol, 10 (1996), pp. 645-671
[22.]
G. Cadiot, R. Lebtahi, L. Sorda, G. Bonnaud, J.P. Marmuse, C. Vissuzaine, et al.
Prospective detection of duodenal gastrónomas and peripancreatic nodes by somatostatin receptors scintigraphy.
Gastroenterology, 111 (1996), pp. 845
[23.]
T. Rosch, C.J. Lightdale, J.F. Botet, G.A. Boyce, M.V. Sivak Jr, K. Yasuda, et al.
Localization of pancreatic endocrine tumors by endoscopic ultrasonography.
N Engl J Med, 326 (1992), pp. 1721-1726
[24.]
J.C. Ardengh, G.A. Paulo, A.P. Ferrari.
EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery.
Gastrointest Endosc, 60 (2004), pp. 378-384
[25.]
A. Gines, E. Vázquez-Sequeiros, M. Soria, J.E. Clain, M.J. Wiersema.
Usefulness of EUS-guided fine needle aspiration (EUSFNA) in the diagnosis of functioning neuroendocrine tumors.
Gastrointest Endosc, 56 (2002), pp. 291-296
[26.]
F.G. Gress, M. Barawi, D. Kim, J.H. Grenda.
Preoperative localization of a neuroendocrine tumor of the pancreas with EUS-guided fine needle tattooing.
Gastrointest Endosc, 55 (2002), pp. 594-597
[27.]
N. Muscatiello, A. Salcuni, L. Macarini, M. Cignarelli, S. Prencipe, M. Di Maso, et al.
Treatment of a pancreatic endocrine tumor by ethanol injection guided by endoscopic ultrasound.
Endoscopy, 40 (2008), pp. E258-E259
Copyright © 2009. Sociedad Española de Endocrinología y Nutrición
